ABO-incompatible liver transplant: Is it justifiable?

Liver Transplantation

Volumn 9, Issue 1, 2003, Pages 31-

  Stegall, Mark ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS;

ANTIBODY TITER; BILIARY TRACT DISEASE; BLOOD COMPATIBILITY; BLOOD GROUP AB; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; BLOOD GROUP O; CADAVER DONOR; CLINICAL PROTOCOL; DETERIORATION; EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; PLASMAPHERESIS; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT OUTCOME;

EID: 0037235106     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.00000     Document Type: Editorial

References (3)

1. Tanabe K, Kozawa O, Kaida T, Matsuno H, Niwa M, Ohta S, Dohi S, et al. Long-term results of ABO-incompatible living kidney transplantation. Transplantation 1998;65:224.
2. Gloor J, Lager DJ, Moore B, Pineda AA, Fidler ME, Larson TS, Grande JP, et al. ABO-incompatibe kidney transplantation using both A2 and non-A2 living donors. Transplantation 2003 (in press).
3. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosupression: evidence for accomodation. Liver Transpl 2003; 9:22-30.